智通财经APP讯,和铂医药-B(02142)发布公告,该公司于2025年4月1日回购174.32万港元回购20万股股份,每股回购价格为8.54-9港元。
于同日,根据于2020年11月23日采纳及获公司股东批准的首次公开发售后股份奖励计划而发行109.53万股普通股以满足股份奖励。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.